|
|
||||||||
Ann Thorac Surg 2005;80:2070-2075
© 2005 The Society of Thoracic Surgeons
a Second Department of Surgery, Fukuoka University School of Medicine, Fukuoka, Japan
b Second Department of Surgery, Oita University Faculty of Medicine, Oita, Japan
Accepted for publication June 3, 2005.
* Address correspondence to Dr Yamamoto, Second Department of Surgery, Fukuoka University School of Medicine, Jyonan-ku Nanakuma 7-45-1, 814-0180, Fukuoka, Japan (Email: y-satosi{at}fukuoka-u.ac.jp).
BACKGROUND: To evaluate whether thoracoscopic and video-assisted dissections are appropriate modalities, we assessed the mortality, morbidity, and survival of patients who underwent a thoracoscopic esophagectomy for esophageal cancer.
METHODS: Between November 1995 and December 2004, thoracoscopic and video-assisted esophagectomies were performed on 112 (72.7%) patients out of 154 who underwent surgical resection for thoracic and abdominal esophageal cancer. The histologic type of cancer was squamous cell carcinoma in 109 (97.4%) patients and adenocarcinoma in 3 (2.6%).
RESULTS: Intraoperative complications occurred in 4 (3.6%) patients: tracheal injury in 3 (2.7%) and azygos vein injury in 1 (0.8%). The 30-day mortality rate was 0.8%. Early postoperative complications occurred in 29 (25.9%) patients including the following: recurrent nerve palsy in 10 (8.9%), respiratory complication in 7 (6.3%), anastomotic leakage in 9 (8.0%) with major leakage requiring reanastomosis in 4 (3.6%) of these 9, and chylothorax in 3 (2.7%). Induction chemoradiotherapy, preoperative concomitant disease, and reconstruction using the colon did not increase morbidity. Port site recurrence occurred in 3 (2.7%) patients. The overall 5-year survival rate was 52%. For stage I disease, the 5-year survival rate of patients was 87.2%. In stage II disease, it was 70.2%.
CONCLUSIONS: Thoracoscopic and video-assisted esophagectomy are considered feasible and safe options for the treatment of esophageal cancer, but further investigation is necessary. The survival of patients with stage I and II disease is satisfactory at the present time.
This article has been cited by other articles:
![]() |
S. F. SCHOPPMANN, G. PRAGER, F. LANGER, M. RIEGLER, E. FLEISCHMAN, and J. ZACHERL Fifty-five Minimally Invasive Esophagectomies: A Single Centre Experience Anticancer Res, July 1, 2009; 29(7): 2719 - 2725. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Zingg, A. McQuinn, D. DiValentino, A. J. Esterman, J. R. Bessell, S. K. Thompson, G. G. Jamieson, and D. I. Watson Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann. Thorac. Surg., March 1, 2009; 87(3): 911 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Decker, W. Coosemans, P. De Leyn, H. Decaluwe, P. Nafteux, D. Van Raemdonck, and T. Lerut Minimally invasive esophagectomy for cancer Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 13 - 21. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |